Literature DB >> 16304165

Enterococcus faecium low-affinity pbp5 is a transferable determinant.

Louis B Rice1, Lenore L Carias, Susan Rudin, Viera Lakticová, Aaron Wood, Rebecca Hutton-Thomas.   

Abstract

Using 15 unrelated Enterococcus faecium isolates as donors, we demonstrated that ampicillin resistance was transferable to an E. faecium recipient containing a pbp5 deletion for all but four strains. The transfers occurred at low frequencies (generally ca. 10(-9) transconjugants/recipient CFU), consistent with chromosome-to-chromosome transfer. pbp5 transfer occurred within large genetic regions, and insertion into the recipient genome occurred most commonly into the recipient SmaI restriction fragment that had been created by the previous pbp5 deletion. Restriction mapping of the region upstream of pbp5 revealed a commonality of fragment sizes among the clinical isolates from the United States which differed significantly from those of three strains that were isolated from turkey feces. These data prove conclusively that E. faecium pbp5 is a transferable determinant, even in the absence of a coresiding vancomycin resistance mobile element. They also suggest that the spread of high-level ampicillin resistance among U.S. E. faecium strains is due in part to the transfer of low-affinity pbp5 between clinical isolates.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16304165      PMCID: PMC1315957          DOI: 10.1128/AAC.49.12.5007-5012.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  22 in total

1.  Molecular analysis of Tn1546-like elements in vancomycin-resistant enterococci isolated from patients in Europe shows geographic transposon type clustering.

Authors:  M A Schouten; R J Willems; W A Kraak; J Top; J A Hoogkamp-Korstanje; A Voss
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

2.  Geographic distribution of a large mobile element that transfers ampicillin and vancomycin resistance between Enterococcus faecium strains.

Authors:  J Hanrahan; C Hoyen; L B Rice
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

3.  Penicillin-binding protein 5 and expression of ampicillin resistance in Enterococcus faecium.

Authors:  L B Rice; L L Carias; R Hutton-Thomas; F Sifaoui; L Gutmann; S D Rudin
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

4.  Vancomycin-resistant enterococci: mechanisms and clinical observations.

Authors:  H S Gold
Journal:  Clin Infect Dis       Date:  2001-06-14       Impact factor: 9.079

5.  One or two low affinity penicillin-binding proteins may be responsible for the range of susceptibility of Enterococcus faecium to benzylpenicillin.

Authors:  R Williamson; C le Bouguénec; L Gutmann; T Horaud
Journal:  J Gen Microbiol       Date:  1985-08

6.  Nosocomial acquisition of beta-lactamase--negative, ampicillin-resistant enterococcus.

Authors:  V A Chirurgi; S E Oster; A A Goldberg; R E McCabe
Journal:  Arch Intern Med       Date:  1992-07

7.  Tn5381, a conjugative transposon identifiable as a circular form in Enterococcus faecalis.

Authors:  L B Rice; S H Marshall; L L Carias
Journal:  J Bacteriol       Date:  1992-11       Impact factor: 3.490

8.  Impact of specific pbp5 mutations on expression of beta-lactam resistance in Enterococcus faecium.

Authors:  Louis B Rice; Samuel Bellais; Lenore L Carias; Rebecca Hutton-Thomas; Robert A Bonomo; Patrick Caspers; Malcolm G P Page; Laurent Gutmann
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

9.  Increasing resistance to beta-lactam antibiotics among clinical isolates of Enterococcus faecium: a 22-year review at one institution.

Authors:  M L Grayson; G M Eliopoulos; C B Wennersten; K L Ruoff; P C De Girolami; M J Ferraro; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

10.  Penicillin-binding protein 5 sequence alterations in clinical isolates of Enterococcus faecium with different levels of beta-lactam resistance.

Authors:  T Rybkine; J L Mainardi; W Sougakoff; E Collatz; L Gutmann
Journal:  J Infect Dis       Date:  1998-07       Impact factor: 5.226

View more
  17 in total

Review 1.  Mechanisms of resistance and clinical relevance of resistance to β-lactams, glycopeptides, and fluoroquinolones.

Authors:  Louis B Rice
Journal:  Mayo Clin Proc       Date:  2012-02       Impact factor: 7.616

2.  Enterococci: on the back burner but still simmering.

Authors:  George M Eliopoulos
Journal:  Curr Infect Dis Rep       Date:  2006-09       Impact factor: 3.725

3.  Analysis of PBP5 of early U.S. isolates of Enterococcus faecium: sequence variation alone does not explain increasing ampicillin resistance over time.

Authors:  Jessica R Galloway-Peña; Louis B Rice; Barbara E Murray
Journal:  Antimicrob Agents Chemother       Date:  2011-05-16       Impact factor: 5.191

4.  Enterococci and Their Interactions with the Intestinal Microbiome.

Authors:  Krista Dubin; Eric G Pamer
Journal:  Microbiol Spectr       Date:  2014-11

Review 5.  Horizontal gene transfer and the genomics of enterococcal antibiotic resistance.

Authors:  Kelli L Palmer; Veronica N Kos; Michael S Gilmore
Journal:  Curr Opin Microbiol       Date:  2010-09-15       Impact factor: 7.934

6.  Mechanism of chromosomal transfer of Enterococcus faecalis pathogenicity island, capsule, antimicrobial resistance, and other traits.

Authors:  Janet M Manson; Lynn E Hancock; Michael S Gilmore
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-21       Impact factor: 11.205

Review 7.  The Enterococcus: a Model of Adaptability to Its Environment.

Authors:  Mónica García-Solache; Louis B Rice
Journal:  Clin Microbiol Rev       Date:  2019-01-30       Impact factor: 26.132

8.  Analysis of clonality and antibiotic resistance among early clinical isolates of Enterococcus faecium in the United States.

Authors:  Jessica R Galloway-Peña; Sreedhar R Nallapareddy; Cesar A Arias; George M Eliopoulos; Barbara E Murray
Journal:  J Infect Dis       Date:  2009-11-15       Impact factor: 5.226

9.  Inhibition of bacterial and fungal pathogens by the orphaned drug auranofin.

Authors:  Beth Burgwyn Fuchs; Rajmohan RajaMuthiah; Ana Carolina Remondi Souza; Soraya Eatemadpour; Rodnei Dennis Rossoni; Daniel Assis Santos; Juliana C Junqueira; Louis B Rice; Eleftherios Mylonakis
Journal:  Future Med Chem       Date:  2016-01-25       Impact factor: 3.808

Review 10.  One ring to rule them all: Current trends in combating bacterial resistance to the β-lactams.

Authors:  Dustin T King; Solmaz Sobhanifar; Natalie C J Strynadka
Journal:  Protein Sci       Date:  2016-03-09       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.